Advance Bio SEC column

Improving Laboratory Workflows

Agilent Technologies has introduced a technology designed to help scientists achieve the reproducible results they need to develop effective biopharmaceuticals. It’s line of Advance Bio SEC columns represent an advance in size-exclusion chromatography, a key technology used to quantify aggregation in biotherapeutics such as monoclonal antibodies.

Quantifying aggregation is a vital factor in developing and producing safe, effective biologics. The columns deliver higher resolution for more accurate quantitation as well as higher sensitivity to quantitate aggregates, even at low levels.

This product information
is expired!

Use our search-function for current products ...
gradient arrows

Agilent Technologies Sales & Services GmbH & Co. KG

Hewlett-Packard-Straße 8
76337 Waldbronn

Phone: +49 (0) 800/ 603- 1000
Fax: +49 (0) 69/ 9530- 7919